within Pharmacolibrary.Drugs.ATC.A;

model A10BB11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 0.016666666666666666,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Glisoxepide is a second-generation sulfonylurea oral hypoglycemic agent formerly used for the management of type 2 diabetes mellitus. It acts by stimulating insulin secretion from pancreatic beta cells. Its use has declined and it is not widely approved or available for current therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameter values are estimated based on general properties of second-generation sulfonylureas, as no direct studies or clinical publication with detailed glisoxepide PK values have been identified.</p><h4>References</h4><ol><li><p>Petzinger, E, &amp; Fückel, D (1992). Evidence for a saturable, energy-dependent and carrier-mediated uptake of oral antidiabetics into rat hepatocytes. <i>European journal of pharmacology</i> 213(3) 381–391. DOI:<a href=&quot;https://doi.org/10.1016/0014-2999(92)90627-g&quot;>10.1016/0014-2999(92)90627-g</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1618279/&quot;>https://pubmed.ncbi.nlm.nih.gov/1618279</a></p></li><li><p>Gutsche, H, &amp; Losert, W (1977). [Clinico-pharmacological studies on the duration of action of the oral antidiabetic drug glisoxepide (author&#x27;s transl)]. <i>Arzneimittel-Forschung</i> 27(9) 1719–1726. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/336058/&quot;>https://pubmed.ncbi.nlm.nih.gov/336058</a></p></li><li><p>Irsigler, K, et al., &amp; Zdolsek, I (1979). [Comparison of glibenclamide, gliquidone, glisoxepide and placebo in maturity onset diabetics of differing degrees of severity (author&#x27;s transl)]. <i>Wiener klinische Wochenschrift</i> 91(16) 541–550. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/115159/&quot;>https://pubmed.ncbi.nlm.nih.gov/115159</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10BB11;
